Related Experiment Video
Updated: Mar 1, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
The human RNA surveillance factor Up-frameshift 1 inhibits hepatic cancer progression by targeting MRP2/ABCC2
Hai Zhang1, Yina You1, Zhongliang Zhu2
1Department of Gastroenterology, Huangshi Central Hospital, The Affiliated Hospital of Hubei Polytechnic University, Huangshi, 435000, China.
Abstract:
Although the roles of Up-frameshift 1 (UPF1) in hepatocellular carcinoma (HCC) have been partly revealed, the detailed mechanisms remain poorly understood. Here, quantitative real-time PCR (qRT-PCR) and immunohistochemistry assays indicated that UPF1 expression was decreased in HCC tissues compared to the corresponding adjacent tissues, and was negatively correlated with MRP2/ABCC2 expression. Cell viability and apoptosis analyses showed that overexpression of UPF1 enhanced HCC cell sensitivity to sorafenib treatment, while knockdown of UPF1 decreased the sensitivity. Additionally, ectopic expression of UPF1 suppressed the epithelial-mesenchymal transition (EMT) process and the generation of cells with stem cell properties. Mechanistically, UPF1 directly bound with ABCC2, increased nonsense-mediated mRNA decay (NMD) efficiency and thus led to downregualtion of ABCC2. Collectively, UPF1 functions as a tumor suppressor by preventing cancer stem cell (CSC)-like characteristics, inhibiting EMT process and enhancing chemotherapeutic sensitivity via inhibiting ABCC2 expression in HCC cells. These findings establish UPF1 as a potential therapeutic target for HCC patients.
Insights
Up-frameshift 1 (UPF1) acts as a tumor suppressor in hepatocellular carcinoma (HCC). It enhances chemotherapy sensitivity by downregulating ABCC2, thereby inhibiting cancer stem cell properties and epithelial-mesenchymal transition.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The precise mechanisms of Up-frameshift 1 (UPF1) in hepatocellular carcinoma (HCC) require further elucidation.
- Previous studies have partially indicated UPF1's involvement in HCC, but a comprehensive understanding of its function is lacking.
Purpose of the Study:
- To investigate the role and underlying mechanisms of UPF1 in hepatocellular carcinoma (HCC).
- To explore UPF1's impact on HCC cell sensitivity to sorafenib, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) properties.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and immunohistochemistry were used to assess UPF1 and ABCC2 expression levels.
- Cell viability, apoptosis assays, and Western blotting were employed to evaluate the functional effects of UPF1.
- Nonsense-mediated mRNA decay (NMD) assays were performed to understand the mechanism of ABCC2 regulation.
Main Results:
- UPF1 expression was significantly decreased in HCC tissues and negatively correlated with MRP2/ABCC2 expression.
- Overexpression of UPF1 increased HCC cell sensitivity to sorafenib, suppressed EMT, and reduced CSC-like properties.
- UPF1 directly bound to ABCC2, enhancing NMD efficiency and leading to ABCC2 downregulation.
Conclusions:
- UPF1 functions as a tumor suppressor in HCC by inhibiting ABCC2 expression, thereby suppressing CSC-like characteristics and EMT.
- UPF1 enhances chemotherapeutic sensitivity in HCC, suggesting its potential as a therapeutic target for HCC patients.
Related Concept Videos
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Abnormal Proliferation
RNA Editing
MicroRNAs
Experimental RNAi

